Gilead Sciences (GILD) Asset Utilization Ratio (2009 - 2026)
Gilead Sciences (GILD) posted Asset Utilization Ratio of 0.52 for Q1 2026, up 2.97% quarter-over-quarter from 0.5 in Q4 2025, and up 3.6% year-on-year from 0.5 in Q1 2025.
Gilead Sciences (GILD) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has reported Asset Utilization Ratio for 18 consecutive years, with 0.52 the latest figure, recorded in Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.52, up 3.6% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.52 (up 3.6% YoY), and the FY2025 annual result was 0.5, up 5.09% from the prior year.
- Asset Utilization Ratio was 0.52 for Q1 2026 at Gilead Sciences, up from 0.5 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.52 in Q3 2024 and troughed at 0.42 in Q1 2022.
- Average Asset Utilization Ratio over 5 years is 0.47, with a median of 0.46 recorded in 2024.
- Year-over-year, Asset Utilization Ratio gained 19.19% in 2024 and declined 2.75% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.43 in 2022, then advanced by 0.38% to 0.44 in 2023, then advanced by 16.3% to 0.51 in 2024, then fell by 1.12% to 0.5 in 2025, then grew by 2.97% to 0.52 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.52 in Q1 2026, 0.5 in Q4 2025, and 0.51 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.63 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.48 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.46 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 0.50 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.50 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.41 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.52 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.12 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.52 |
| Dec 31, 2025 | 0.50 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | 0.50 |
| Dec 31, 2024 | 0.51 |
| Sep 30, 2024 | 0.52 |
| Jun 30, 2024 | 0.51 |
| Mar 31, 2024 | 0.46 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.44 |
| Jun 30, 2023 | 0.44 |
| Mar 31, 2023 | 0.43 |
| Dec 31, 2022 | 0.43 |
| Sep 30, 2022 | 0.43 |
| Jun 30, 2022 | 0.44 |
| Mar 31, 2022 | 0.42 |
| Dec 31, 2021 | 0.40 |
| Sep 30, 2021 | 0.41 |
| Jun 30, 2021 | 0.39 |